A new genetic testing method developed by researchers at the University of Nottingham and Nottingham University Hospitals (NUH) NHS Trust has significantly reduced the time required to diagnose brain tumours from weeks to mere hours. This "ultra-rapid" testing technique, which has already been implemented in 50 operations at NUH with a 100% success rate for accurate tumour type identification, is garnering attention across various NHS facilities in the UK.
Traditionally, diagnosing brain tumours has involved extracting samples during surgery and sending them for lab analysis, a process that can take up to eight weeks. This delay often necessitates additional surgeries if a more aggressive treatment is required, as neurosurgeon Stuart Smith noted. The new method, leveraging nanopore genetic sequencing and specialized software, allows for results to be returned in as fast as 90 minutes, enabling surgeons to make informed decisions during the initial operation.
The implications of this rapid testing are significant. Faster diagnoses could lead to timely treatments such as chemotherapy or radiation, potentially reducing patient anxiety associated with prolonged waiting periods. Professor Matt Loose, who has been developing this technique since 2018, emphasized that quicker results could be critical for patients with aggressive tumours.
Patient experiences underscore the importance of this advancement. For instance, Gemma's daughter, Nancy, underwent two surgeries and chemotherapy after a lengthy wait for diagnosis. The new method could have potentially spared her from additional surgeries. Another patient, Charles Trigg, highlighted how early knowledge of his diagnosis provided clarity and allowed for better planning.
Organizations like The Brain Tumour Charity have recognized the transformative potential of this rapid testing in ensuring timely access to optimal care for patients facing brain tumour diagnoses. Several hospitals, including Queen Elizabeth Hospital Birmingham and Great Ormond Street Children's Hospital, are adopting this testing method alongside existing procedures to enhance patient outcomes.